Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

International Women’s Day

8/03/2022
On International Women’s Day, we celebrate all women in science and health. The OraSure family of companies, including Diversigen, DNA Genotek, and Novosanis, are proud to include a diverse, and international team of women, across various roles and divisions. For this years' blog, we honor all the...
Read more

Latest blogpost

View all blogs

Urine as a sample type for HPV detection and cervical cancer screening - Highlights from Eurogin 2022

13/05/2022
In April 2022, our team was present with a booth at Eurogin in Düsseldorf , a leading conference focusing on Human Papillomavirus (HPV) . It was a great place to share our latest work and stay up to date in the field of cervical cancer and other HPV-related diseases . We have three main takeaways...
Read more

Upcoming event

View all events

EACR Conference Liquid Biopsies

Bergamo, Italy
8
Novosanis will be present at the EACR Conference on Liquid Biopsies in Bergamo, Italy between May 24-26 2022. Our team is excited to participate in latest scientific discussions on the role of liquid biopsies in cancer research. We will also share our work on the potential of urine as liquid biopsy...
Read more